InternationalUSRemember you can easily switch between MIP US and MIP International at any time
Please note: On the LinkedIn and Twitter websites any comments made should be in accordance with their user terms. (LinkedIn terms and conditions, Twitter terms and conditions). Managing IP does not moderate comments and the opinions expressed are those of the individual group members only. They do not reflect those of Managing IP and Managing IP accepts no responsibility, legal or otherwise, for the accuracy or content of comments.
profile

Managing IP

ManagingIP

ManagingIP profile

New IP round-up from @mdloney, featuring biosimilars complaint, SiriusXM ruling, ED of Tex filing slump and more! https://t.co/1szaMeR3j1

Feb 23 2017 05:44 ·  reply ·  retweet ·  favourite
ManagingIP profile

Our analysis of SCOTUS Life Tech v Promega ruling https://t.co/CL6Ibt23RO Court didn't indicate how many components enough for infringement

Feb 23 2017 05:30 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @PatentScholar: SCOTUS opinion in LifeTech v. Promega is out—supply of single component doesn't lead to §271(f)(1) liability https://t.c

Feb 22 2017 04:57 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


February 2017

Top firms for trade marks 2017

Find out which firms are ranked in the first part of this year’s IP Stars research. Below, we provide a guide to the research and methodology



Most read articles

Supplements